Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The lung and primary immunodeficiency.

A Cantani1, M Ferrara

  • 1Department of Pediatrics, University of Rome La Sapienza, Italy.

Allergologia Et Immunopathologia
|November 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study.

ESMO gastrointestinal oncology·2026
Same author

Results on Listeria monocytogenes Strains From Ready-to-Eat Meat Products and Food Production Environments in Namibia, Sudan, and Zambia: A Focus on Genomic Characterization of Strains.

Journal of food protection·2026
Same author

Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experience.

ESMO gastrointestinal oncology·2026
Same author

Eye-tracking metrics as a new tool to assess patient's adherence to robot-assisted gait training.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry.

The Journal of antimicrobial chemotherapy·2025
Same author

Effects of Visual and Verbal Feedback on Active Patient Participation During Robot-Assisted Gait Training.

IEEE ... International Conference on Rehabilitation Robotics : [proceedings]·2025
Same journal

Peach sublingual immunotherapy for lipid transfer protein syndrome.

Allergologia et immunopathologia·2026
Same journal

Gastrointestinal stenosis: an underrecognized complication of CARMIL2 deficiency.

Allergologia et immunopathologia·2026
Same journal

Peach sublingual immunotherapy for lipid transfer protein syndrome.

Allergologia et immunopathologia·2026
Same journal

Vitamin B12 allergy and desensitization.

Allergologia et immunopathologia·2026
Same journal

Chronic HBV infection, stemness pathways, and compromised immune surveillance in HCC development.

Allergologia et immunopathologia·2026
Same journal

Application of FeNO in the diagnostic and therapeutic algorithm of pediatric asthma: From chronic cough and wheeze to personalized management.

Allergologia et immunopathologia·2026
See all related articles

Primary immunodeficiencies (ID) increasingly affect the respiratory system, often leading to severe infections and early death. Early treatment with intravenous immunoglobulin (IVIG) can prevent bronchiectasis and improve patient outcomes.

Area of Science:

  • Immunology
  • Pulmonology
  • Genetics

Background:

  • Primary immunodeficiencies (ID) are increasingly diagnosed due to advances in immunology and diagnostics.
  • The respiratory system, particularly the lungs, is a common target for primary ID.
  • Untreated immune defects frequently cause respiratory infections and failure, leading to early mortality.

Purpose of the Study:

  • To highlight the significant impact of primary immunodeficiencies on respiratory health.
  • To emphasize the role of early diagnosis and intervention in managing these conditions.
  • To discuss the effectiveness of current treatments in improving patient prognosis.

Main Methods:

  • Review of current immunological knowledge and diagnostic techniques for primary ID.

Related Experiment Videos

  • Analysis of clinical outcomes in patients with primary ID affecting the respiratory tract.
  • Evaluation of the impact of intravenous immunoglobulin (IVIG) therapy on preventing bronchiectasis.

    • Main Results:

    • Respiratory infections and failure are leading causes of mortality in uncorrected primary ID.
    • A majority of patients with Ig deficiency develop chronic respiratory infections and bronchiectasis.
    • Early IVIG administration is effective in preventing bronchiectasis and improving quality of life.

    Conclusions:

    • Early recognition and management of primary immunodeficiencies are crucial for preventing severe respiratory complications.
    • Intravenous immunoglobulin therapy significantly improves outcomes for patients with Ig deficiency, reducing the incidence of bronchiectasis.
    • Advances in diagnostics and treatment offer better prognoses and enhanced quality of life for individuals with primary ID.